GeneCure Biotechnologies   Report issue

For profit Phase 1
Founded: Norcross GA United States (1998)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
2010
NCT01428596
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

GeneCure Biotechnologies

Active Ingredients

Drugs in Phase 1 Trials (3)

covax-19 (1 trial)

hcvax (1 trial)

hivax (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 1)

Hepatitis A (Phase 1)

Hepatitis C (Phase 1)

Hepatitis C, Chronic (Phase 1)

Hepatitis, Chronic (Phase 1)

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 3